Literature DB >> 14715840

Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.

Jan Skrha1, Tomás Haas, Gustav Sindelka, Martin Prázný, Jirí Widimský, David Cibula, Stepán Svacina.   

Abstract

The aim of this study was to compare insulin sensitivity expressed by the hyperinsulinemic clamp and by the homeostasis model assessment (HOMA) and QUICKI indexes in subjects with various disorders influencing insulin action. We examined 41 type 2 diabetic patients, 20 insulinoma patients, 32 women with polycystic ovary syndrome, 16 patients with primary hyperaldosteronism, 12 patients with essential high renin hypertension, and 47 healthy subjects. The metabolic clearance rate of glucose and the insulin sensitivity index calculated from the clamps were compared with both the HOMA and QUICKI indexes. The relationship of insulin action to body mass index, serum cholesterol, and triglycerides as well as to systolic and diastolic blood pressures was also evaluated. Body mass index was very strongly associated with the insulin sensitivity index (r = -0.70; P < 0.0001) in the entire cohort of 168 subjects. Cholesterol, triglycerides, and blood pressure influenced insulin action in the healthy subjects and type 2 diabetic patients. A significant relationship was observed between the insulin sensitivity index and the HOMA or QUICKI indexes in healthy subjects (r = -0.66; P < 0.0001), type 2 diabetic patients (r = -0.68; P < 0.0001), and women with polycystic ovary syndrome (r = -0.65; P < 0.0001). We did not find any relationship between the above variables in the patients with insulinoma or primary hyperaldosteronism. The HOMA and QUICKI indexes do not offer the same information as glucose clamps in the rare cases with differently impaired peripheral or hepatic insulin action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715840     DOI: 10.1210/jc.2002-030024

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting.

Authors:  P A Velasquez-Mieyer; P A Cowan; C P Neira; F Tylavsky
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

3.  Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects.

Authors:  J Polak; C Moro; E Klimcakova; J Hejnova; M Majercik; N Viguerie; D Langin; M Lafontan; V Stich; M Berlan
Journal:  Diabetologia       Date:  2005-11-05       Impact factor: 10.122

4.  Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; Martinho Antonio Gestic; Murillo Pimentel Utrini; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

5.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats.

Authors:  Ranganath Muniyappa; Hui Chen; Radhika H Muzumdar; Francine H Einstein; Xu Yan; Lilly Q Yue; Nir Barzilai; Michael J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

6.  Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males.

Authors:  Alexander W Krug; Lissy Stelzner; Ajaykumar D Rao; Andrew H Lichtman; Gordon H Williams; Gail K Adler
Journal:  Metabolism       Date:  2012-09-21       Impact factor: 8.694

Review 7.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

8.  Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.

Authors:  Hang Xiang; Chao Yang; Tianyuan Xiang; Zheng Wang; Xin Ge; Fan Li; Yuehan Su; Haixu Chen; Xianyong Huang; Qiang Zeng
Journal:  Stem Cells Transl Med       Date:  2016-03-29       Impact factor: 6.940

9.  A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances.

Authors:  F Ramezani Tehrani; S Behboudi-Gandevani; M Simbar; F Azizi
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

10.  Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance.

Authors:  Ho Hyun Nam; Dae Won Jun; Hye Joon Jeon; Jai Sun Lee; Waqar Khalid Saeed; Eun Kyung Kim
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.